Amgen’s stock falls as analyst warns that hype around obesity drug is baked in
Truist analyst Srikripa Devarakonda backs away from bullish call as competition mutes potential for biotech’s drug pipeline.
Southwest Airlines’ stock took a turn lower Monday, after activist investor Elliott Investment Management called for a special meeting to...
Barring an economic slowdown, market conditions are still favorable, with interest rates expected to continue to come down and investors...
”I haven’t heard of anyone doing this, so I’m not sure it’s even legal.”
These 20 stocks are being unfairly punished. They’ll likely bounce back in January.
An Evercore ISI analyst thinks Apple looks primed to capitalize on low investor expectations for the latest quarter.
Investment bank’s stock is down 73% in the year to date amid regulatory fallout over a loan
Average Rating